These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 11697285

  • 21. [Hemodynamics of massive obesity].
    Valensi P.
    Rev Prat; 1993 Oct 01; 43(15):1918-23. PubMed ID: 8310245
    [Abstract] [Full Text] [Related]

  • 22. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH, Alfayoumi F.
    Prog Cardiovasc Dis; 2006 Oct 01; 48(5):326-41. PubMed ID: 16627048
    [Abstract] [Full Text] [Related]

  • 23. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
    Golan E, Tal B, Dror Y, Korzets Z, Vered Y, Weiss E, Bernheim J.
    Isr Med Assoc J; 2002 Jun 01; 4(6):426-30. PubMed ID: 12073415
    [Abstract] [Full Text] [Related]

  • 24. The relationship between blood pressure and left ventricular mass index depends on an excess adiposity.
    Norton GR, Majane OH, Libhaber E, Maseko MJ, Makaula S, Libhaber C, Woodiwiss AJ.
    J Hypertens; 2009 Sep 01; 27(9):1873-83. PubMed ID: 19512944
    [Abstract] [Full Text] [Related]

  • 25. [Obesity and the heart].
    Barzizza F.
    Minerva Gastroenterol Dietol; 2001 Dec 01; 47(4):229-34. PubMed ID: 16493382
    [Abstract] [Full Text] [Related]

  • 26. Clinical evidence for drug treatments in obesity-associated hypertensive patients--a discussion paper.
    Doggrell SA.
    Methods Find Exp Clin Pharmacol; 2005 Mar 01; 27(2):119-25. PubMed ID: 15834464
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA, Cowan PA, Velasquez-Mieyer P, Patton SB.
    J Am Acad Nurse Pract; 2007 Jul 01; 19(7):368-77. PubMed ID: 17680902
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A comparison of body mass index and waist-to-hip ratio as indicators of hypertension risk in an urban Argentine population: a hospital-based study.
    Feldstein CA, Akopian M, Olivieri AO, Kramer AP, Nasi M, Garrido D.
    Nutr Metab Cardiovasc Dis; 2005 Aug 01; 15(4):310-5. PubMed ID: 16054556
    [Abstract] [Full Text] [Related]

  • 31. Effect of orlistat on cardiovascular disease risk in obese adults.
    Swinburn BA, Carey D, Hills AP, Hooper M, Marks S, Proietto J, Strauss BJ, Sullivan D, Welborn TA, Caterson ID.
    Diabetes Obes Metab; 2005 May 01; 7(3):254-62. PubMed ID: 15811142
    [Abstract] [Full Text] [Related]

  • 32. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
    Klein S, Burke LE, Bray GA, Blair S, Allison DB, Pi-Sunyer X, Hong Y, Eckel RH, American Heart Association Council on Nutrition, Physical Activity, and Metabolism.
    Circulation; 2004 Nov 02; 110(18):2952-67. PubMed ID: 15509809
    [Abstract] [Full Text] [Related]

  • 33. Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels.
    Cortés R, Otero MR, Morillas P, Roselló-Lletí E, Grigorian L, Martínez-Dolz L, de Burgos FG, Calabuig JR, Soria F, Lozano T, Portolés M, Bertomeu V.
    Am J Hypertens; 2008 Jul 02; 21(7):820-5. PubMed ID: 18443568
    [Abstract] [Full Text] [Related]

  • 34. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM, Berber A, Macias-Lara CC, Lucio-Ortiz C, Del-Rio-Navarro BE, Dorantes-Alvárez LM.
    Clin Ther; 2006 May 02; 28(5):770-82. PubMed ID: 16861099
    [Abstract] [Full Text] [Related]

  • 35. Obesity and hypertension: epidemiological aspects of the relationship.
    Heyden S, Schneider KA.
    J Hum Hypertens; 1990 Aug 02; 4(4):431-5. PubMed ID: 2258890
    [Abstract] [Full Text] [Related]

  • 36. [Hypertension in chronic kidney failure (the physiopathology, clinical picture and treatment)].
    Covic A.
    Rev Med Chir Soc Med Nat Iasi; 1997 Aug 02; 101(3-4):30-8. PubMed ID: 10756768
    [Abstract] [Full Text] [Related]

  • 37. Hypertension and obesity.
    Dustan HP.
    Prim Care; 1991 Sep 02; 18(3):495-507. PubMed ID: 1946785
    [Abstract] [Full Text] [Related]

  • 38. Obesity-associated hypertension: hypothesized link between etiology and selection of therapy.
    Reisin E, Tuck ML.
    Blood Press Monit; 1999 Sep 02; 4 Suppl 1():S23-6. PubMed ID: 10822414
    [Abstract] [Full Text] [Related]

  • 39. [Hypertension and the heart].
    Wachtell K, Andersen NH, Svendsen TL.
    Ugeskr Laeger; 2009 Jun 15; 171(25):2113-6. PubMed ID: 19671394
    [Abstract] [Full Text] [Related]

  • 40. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
    Tzotzas T, Samara M, Constantinidis T, Tziomalos K, Krassas G.
    Angiology; 2007 Jun 15; 58(1):26-33. PubMed ID: 17351155
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.